Financing type:  underwritten prospectus offering

Gross proceeds:  $44,022,000 (including the gross proceeds from the exercise of the overallotment option)

Offering:  87 million listed shares with 43.5 million warrants

Offering price:  50 cents per listed share

Warrant exercise terms:  65 cents per listed share for a three-year period

Overallotment option:  The underwriters may purchase a maximum of 13.05 million listed shares and 6,525,000 warrants for overallotment purposes. As of Nov. 5, 2025, such option has been exercised and 6,525,000 warrants have been issued thereunder. All information presented herein includes such exercise.

Commissions in securities:  5,175,000 agent's warrants

Commission terms:  Each non-transferable warrant is exercisable at 50 cents for a three-year period.

Disclosure:  Refer to the prospectus supplement dated Oct. 3, 2025, and the company's news releases dated Oct. 1, 2025, Oct. 9, 2025, and Oct. 31, 2025.